Bristol circulating "Pharmaceutical Security Initiative" anticounterfeiting proposal to industry.
Executive Summary
BRISTOL "PHARMACEUTICAL SECURITY INITIATIVE" PROPOSAL CIRCULATING to other pharmaceutical companies, Bristol-Myers Squibb VP-Corporate Security John Glover told the Drug Information Association annual meeting in San Diego June 10. Bristol is proposing combined action on the part of corporate security directors to combat drug counterfeiting.